Influenza

 
With the Flu Season in Overdrive, Hospitals are Overwhelmed
February 12, 2025

Some hospitals have EDs filled with patients and a number of states are reporting the 2024-2025 version of a COVID-19, flu, and RSV tripledemic.

COVID-19 Associated with Higher Long-Term Mortality Than Flu or RSV: New Data
February 03, 2025

Researchers found that COVID-19 had a higher long-term mortality than influenza and RSV in veterans—underscoring vaccination’s vital role.

Sanofi Investigational COVID-19/Influenza Combination Vaccines Granted FDA Fast-Track Designation
December 18, 2024

The 2 novel vaccine candidates each combine a Sanofi licensed influenza vaccine with the Novavax adjuvanted recombinant COVID-19 vaccine.

A Vaccination Imperative: "Please, Let's Do It," NFID Medical Director Robert Hopkins, Jr, MD, Urges
December 18, 2024

The National Foundation for Infectious Diseases medical director appeals to the community at large to set politics and personal grievance aside and to "first, do no harm."

US Adults Lagging in Flu, COVID-19, and RSV Vaccination: Daily Dose
December 18, 2024

Your daily dose of the clinical news you may have missed.

FDA Lifts Clinical Hold on Novavax’s COVID-19-Influenza Combination Vaccine
November 12, 2024

The FDA cleared Novavax to start enrolling the planned phase 3 trial after a safety concern was found to be unrelated to the combination vaccine.

November Issue of Patient Care Online Digital Edition is Now Live
November 11, 2024

Find details on the surge in US pertussis cases, the first self-administered flu vaccine, and study findings underscoring the evolving nature of long COVID.

Respiratory Virus Season 2024-2025: Expert Insights to Help Primary Care Prepare
November 11, 2024

Insights on how to manage the "triple threat" of flu, RSV, and COVID-19 this season.

Social, Racial Disparities in Flu, COVID-19, RSV Vaccine Uptake: Daily Dose
October 31, 2024

Your daily dose of the clinical news you may have missed.

IDWeek 2024: Novavax Reports Positive Data for Novel Influenza and Flu-COVID-19 Combination Vaccines
October 18, 2024

IDWeek2024: The nanoparticle influenza vaccine and combination flu-Covid-19 shot produced immunogenicity comparable to or higher than comparator vaccines.